Urine and blood tests may predict kidney cancer treatment success
NCT ID NCT07406646
First seen Feb 17, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study looked at 91 adults with advanced kidney cancer to see if tiny particles in blood and urine (called exosomal miRNAs) can predict how well treatment works. Patients were treated with standard therapies like immune checkpoint inhibitors or targeted drugs. Researchers collected samples over 16 weeks and compared them to imaging results. The goal was to find a simple, non-invasive way to predict treatment response early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.